Matches in Nanopublications for { <http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT> ?p ?o ?g. }
- OBJECT label "the incidence of PONV ( 3.05 % , 22/721 )" provenance.
- OBJECT label "the incidence of PONV ( 3.05 % , 22/721 )" provenance.
- OBJECT label "the incidence of PONV ( 3.05 % , 22/721 )" provenance.
- OBJECT label "the incidence of PONV ( 3.05 % , 22/721 )" provenance.
- OBJECT label "the incidence of PONV ( 3.05 % , 22/721 )" provenance.
- OBJECT label "better 28-day survival in severe COVID-19 patients requiring ventilation or oxygen" provenance.
- OBJECT label "better 28-day survival in severe COVID-19 patients requiring ventilation or oxygen" provenance.
- OBJECT label "better 28-day survival in severe COVID-19 patients requiring ventilation or oxygen" provenance.
- OBJECT label "better 28-day survival in severe COVID-19 patients requiring ventilation or oxygen" provenance.
- OBJECT label "better 28-day survival in severe COVID-19 patients requiring ventilation or oxygen" provenance.
- OBJECT label "better 28-day survival in severe COVID-19 patients requiring ventilation or oxygen" provenance.
- OBJECT label "better 28-day survival in severe COVID-19 patients requiring ventilation or oxygen" provenance.
- OBJECT label "better 28-day survival in severe COVID-19 patients requiring ventilation or oxygen" provenance.
- OBJECT label "better 28-day survival in severe COVID-19 patients requiring ventilation or oxygen" provenance.
- OBJECT label "better 28-day survival in severe COVID-19 patients requiring ventilation or oxygen" provenance.
- OBJECT label "better 28-day survival in severe COVID-19 patients requiring ventilation or oxygen" provenance.
- OBJECT label "better 28-day survival in severe COVID-19 patients requiring ventilation or oxygen" provenance.
- OBJECT label "better 28-day survival in severe COVID-19 patients requiring ventilation or oxygen" provenance.
- OBJECT label "better 28-day survival in severe COVID-19 patients requiring ventilation or oxygen" provenance.
- OBJECT label "better 28-day survival in severe COVID-19 patients requiring ventilation or oxygen" provenance.
- OBJECT label "better 28-day survival in severe COVID-19 patients requiring ventilation or oxygen" provenance.
- OBJECT label "with usual care or placebo ( 3 trials , 1282 patients , and 527 deaths )" provenance.
- OBJECT label "with usual care or placebo ( 3 trials , 1282 patients , and 527 deaths )" provenance.
- OBJECT label "with usual care or placebo ( 3 trials , 1282 patients , and 527 deaths )" provenance.
- OBJECT label "with usual care or placebo ( 3 trials , 1282 patients , and 527 deaths )" provenance.
- OBJECT label "with usual care or placebo ( 3 trials , 1282 patients , and 527 deaths )" provenance.
- OBJECT label "with usual care or placebo ( 3 trials , 1282 patients , and 527 deaths )" provenance.
- OBJECT label "with usual care or placebo ( 3 trials , 1282 patients , and 527 deaths )" provenance.
- OBJECT label "with usual care or placebo ( 3 trials , 1282 patients , and 527 deaths )" provenance.
- OBJECT label "reduce mortality in COVID-19 patients in hospital" provenance.
- OBJECT label "reduce mortality in COVID-19 patients in hospital" provenance.
- OBJECT label "reduce mortality in COVID-19 patients in hospital" provenance.
- OBJECT label "reduce mortality in COVID-19 patients in hospital" provenance.
- OBJECT label "reduce mortality in COVID-19 patients in hospital" provenance.
- OBJECT label "reduce mortality in COVID-19 patients in hospital" provenance.
- OBJECT label "reduce mortality in COVID-19 patients in hospital" provenance.
- OBJECT label "reduce mortality in COVID-19 patients in hospital" provenance.
- OBJECT label "transactivation of nuclear factor ( NF)-κ Bwithout inhibiting translocation of the nuclear factor ( NF)-κ B p65 subunit to the nucleus" provenance.
- OBJECT label "transactivation of nuclear factor ( NF)-κ Bwithout inhibiting translocation of the nuclear factor ( NF)-κ B p65 subunit to the nucleus" provenance.
- OBJECT label "transactivation of nuclear factor ( NF)-κ Bwithout inhibiting translocation of the nuclear factor ( NF)-κ B p65 subunit to the nucleus" provenance.
- OBJECT label "transactivation of nuclear factor ( NF)-κ Bwithout inhibiting translocation of the nuclear factor ( NF)-κ B p65 subunit to the nucleus" provenance.
- OBJECT label "transactivation of nuclear factor ( NF)-κ Bwithout inhibiting translocation of the nuclear factor ( NF)-κ B p65 subunit to the nucleus" provenance.
- OBJECT label "transactivation of nuclear factor ( NF)-κ Bwithout inhibiting translocation of the nuclear factor ( NF)-κ B p65 subunit to the nucleus" provenance.
- OBJECT label "the production of and damaging effect of pro-inflammatory cytokines" provenance.
- OBJECT label "the production of and damaging effect of pro-inflammatory cytokines" provenance.
- OBJECT label "the production of and damaging effect of pro-inflammatory cytokines" provenance.
- OBJECT label "the production of and damaging effect of pro-inflammatory cytokines" provenance.
- OBJECT label "the production of and damaging effect of pro-inflammatory cytokines" provenance.
- OBJECT label "the production of and damaging effect of pro-inflammatory cytokines" provenance.
- OBJECT label "that inflammation has a causal role in death" provenance.
- OBJECT label "that inflammation has a causal role in death" provenance.
- OBJECT label "that inflammation has a causal role in death" provenance.
- OBJECT label "that inflammation has a causal role in death" provenance.
- OBJECT label "that inflammation has a causal role in death" provenance.
- OBJECT label "that inflammation has a causal role in death" provenance.
- OBJECT label "that inflammation has a causal role in death" provenance.
- OBJECT label "that inflammation has a causal role in death" provenance.
- OBJECT label "that inflammation has a causal role in death" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.